Nektar Therapeutics NKTR
NASDAQ NKTR
$37.83 +0.57 (+1.52%)
At close: Nov 9, 2026 · 4:00 PM EST

Nektar Therapeutics (NKTR) Return on Invested Capital [ROIC] (2011 - 2020)

Updated

Nektar Therapeutics' Return on Invested Capital [ROIC] came in at -37.82% for Q4 2020, down 13.67 percentage points from -24.14% a year earlier and down 2.88 percentage points from the prior quarter.

Analysis

Nektar Therapeutics (NKTR) Return on Invested Capital [ROIC] (2011 - 2020) Analysis & Trends

For FY2020, Nektar Therapeutics' Return on Invested Capital [ROIC] was -28.48%, down 5.75 percentage points from FY2019.

  • Return on Invested Capital [ROIC] carries a five-year change of -14.13 percentage points (FY2015 to FY2020).
  • Going back by year, Return on Invested Capital [ROIC] was -22.72% in FY2019 (-82.48 pp), 59.76% in FY2018 (+77.71 pp), -17.95% in FY2017 (+20.99 pp) and -38.93% in FY2016 (-24.59 pp).
  • The Q4 2020 figure represents the lowest quarterly Return on Invested Capital [ROIC] since Q2 2017.
  • Year-over-year, Return on Invested Capital [ROIC] has declined for seven consecutive quarters, with an average year-over-year change of -30.46 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Invested Capital [ROIC] over five years came in Q2 2018 (a gain of 140.41 percentage points), and the weakest in Q2 2019 (a drop of 100.20 percentage points).
  • Business Quant data shows NKTR's Return on Invested Capital [ROIC] at -34.94% (Q3 2020), -27.42% (Q2 2020) and -24.40% (Q1 2020) in the three quarters before Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 38.16%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 17.57%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 24.28%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 2.88%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 24.11%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 15.60%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -6.11%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 12.34%
10 Nektar Therapeutics 1.25 Bn -515.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -37.82%
Sep 30, 2020 -34.94%
Jun 30, 2020 -27.42%
Mar 31, 2020 -24.40%
Dec 31, 2019 -24.14%
Sep 30, 2019 -24.23%
Jun 30, 2019 -23.23%
Mar 31, 2019 33.95%
Dec 31, 2018 34.32%
Sep 30, 2018 36.72%
Jun 30, 2018 76.97%
Mar 31, 2018 -28.87%
Dec 31, 2017 -18.02%
Sep 30, 2017 -23.50%
Jun 30, 2017 -63.44%
Mar 31, 2017 -50.89%
Dec 31, 2016 -44.54%
Sep 30, 2016 -58.17%
Jun 30, 2016 -34.48%
Mar 31, 2016 -33.43%
API Access

Nektar Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=NKTR&period=max&api_key=YOUR_API_KEY